A carregar...

Harm reduction program and hepatitis C prevalence in people who inject drugs (PWID) in Iran: an updated systematic review and cumulative meta-analysis

BACKGROUND: Prevalence of hepatitis C virus (HCV) infection among people who inject drugs (PWID) in Iran is high. Since 2005, the Iranian government has implemented a harm reduction program to control HCV. We aimed to describe the prevalence of HCV antibody (Ab) in Iranian PWID before and after the...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Harm Reduct J
Main Authors: Rajabi, Abdolhalim, Sharafi, Heidar, Alavian, Seyed Moayed
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2021
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7825164/
https://ncbi.nlm.nih.gov/pubmed/33482831
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12954-020-00441-9
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!